This behavioral change in clonal macrophages aligns with other reports that identified macrophages with TET2 mutations, frequently found in myeloid neoplasms, to drive aberrant inflammation in vivo by releasing inflammatory cytokines [32, 38]. The gene discussed is TET2; the disease is myeloid neoplasm.